Cannabis Report
Home > Boards > US OTC > Medical - Healthcare >

Progressive Care, Inc. (RXMD)

Add RXMD Price Alert      Hide Sticky   Hide Intro
Moderator: HeadHunter, stockforce, CaptHowdy, times2times2, Davis_Elite, TrackDude
Search This Board: 
Last Post: 7/23/2018 9:42:12 AM - Followers: 637 - Board type: Free - Posts Today: 7

  Progressive Care, Inc. (OTCQB: RXMD)

2016 Net Revenue: $18.32M
2017 Net Revenue: $20.1M
Uplisted to OTCQB on 12/5/2017
901 N Miami Beach Blvd, Suite 1-2
North Miami Beach, FL 33162

Phone: 305-919-7399


Progressive Care's Newly Acquired Pharmacy - Touchpoint Rx, LLC

PharmCo Pharmacy Team



MIAMI, March 22, 2018 — Progressive Care Inc. (OTCQB: RXMD), a healthcare services and technology company, announces 2017 annual results. 

The Company announced over $20 million in net revenues, a 10% increase over 2016, and positive earnings of approximately $50,000. This represents the second consecutive year that the company has accomplished net positive earnings in its audited financial statements. Cost of goods sold increased relative to sales due to increases in DIR and other PBM fees implemented in 2017 as compared to 2016. Prescriptions filled increased 5% to over 225,000 during 2017. The company also filled over $2.7 million worth of prescriptions (Not Included in Net Revenues) for 340B entities during 2017, generating fees to the pharmacy of approximately $113,000, which is over a 400% increase over 2016. 

The annual report showcased the continued development of the Company’s portfolio of healthcare services. Noted within the Management Discussions are the key accomplishments of 2017 which include uplisting to OTCQB, the addition of independent board members, tele-pharmacy platform development, 12 non-resident state licenses and a 5 star pharmacy rating. The performance of the pharmacy has been recognized by Outcomes, the leading MTM platform, and Humana’s Quality Network for reaching performance metrics in key areas. 

The Company has declared ambitious plans during the 2018 fiscal year starting with the announcement of a planned acquisition of a pharmacy in Palm Beach County. In addition to year-over-year sales growth and profitability, the Company plans to expand into the development of proprietary products and technologies that will further diversify the Company’s healthcare service model. Though there are many risks disclosed in the annual report that stem from changes in the industry and government regulation to unforeseen market turndowns, the Company has a positive outlook on the coming year. 

“Filing our second year of audited financial statements 10 days early has a profound significance for me personally,” stated S. Parikh Mars, CEO. “In all the years, I have worked with Progressive Care both inside and out, we were not able to accomplish this goal until now. I could not be prouder of the accounting team we have put together this year and a staff that knows how to do things right every day. I hope that we are delivering the transparency our shareholders expect and the results that motivate them to keep believing in this company.” 

Get connected and stay in touch with us on social media: 

Progressive Care Inc. 

PharmCo, LLC 

WOW! The company also filled over $2.7 million worth of prescriptions (Not Included in Net Revenues) for 340B entities during 2017, generating fees to the pharmacy of approximately $113,000, which is over a 400% increase over 2016. 

Progressive Care Executes Letter of Intent to Purchase a Pharmacy in Palm Beach County - March 2, 2018

Progressive Care Breaks Record with Over 23,000 Prescriptions Filled in January 2018

$1.8 million in net revenues + $450,000 340B revenue = $2.25 million revenue in January, 2018!!!

PharmCo Video for new investors. All people in this video are real PharmCo employees and customers. 

PharmCo Rx Pharmacy is a full-service pharmacy that is unlike any other pharmacy in South Florida. We provide each individual patient with a dedicated, highly qualified team to ensure that the respective needs of all our patients are met quickly and affordably. We are completely dedicated to serving our communities at all times. We proudly support Empower “U¨, PRIDE, Care Resources and many other charitable organizations throughout South Florida. The PharmCo team supports organizations of all religions and faiths, working to bring supplies, food, education and information to all people in need. PharmCo is pleased to sponsor health fairs and local outreach programs in all communities throughout South Florida. 

The following are our strategic goals for 2018:

  • Achieve 25,000 prescriptions filled in a single month by December 2018
    Increase annual overall sales to $22 million
    Secure additional 340B contracts and long term care facility relationships
    Further expansion into Palm Beach County
    Achieve accreditation for non-sterile compounding
    Achieve full enterprise profitability and earnings growth
    Publish 2nd year of audited financial statements and leverage these statements to secure new investment opportunities for mergers and acquisitions
    Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities.
    Strengthening our tele-pharmacy platform

Closing Remarks

The strength of Progressive Care has always been in the hands of its employees and its shareholders. Without the loyalty and dedication of both, this Company would not be where it is today. We have thrived because of the unyielding support in the face of immense challenges and we know that we must never waver in our desire to always earn the trust that has been bestowed upon us. Thank you to all who believe in us and we look forward to delivering another phenomenal year.

    RXMD Security Details

Authorized Shares- 500,000,000 a/o Feb 28, 2018
Outstanding Shares- 370,999,201 a/o Feb 28, 2018
Float 313,793,000 a/o Aug 30, 2017

2013 net revenue: $9.33M 
2014 net revenue: $11.27M 
2015 net revenue: $13.64M 
2016 net revenue: $18.32M 
2017 net revenue: $20.1M 

Business Description
Progressive Care, Inc., through its subsidiary, PharmCo, LLC, engages in the distribution of pharmaceuticals. PharmCo also provides related pharmacy consulting, and durable medical equipment and accessories to retail and long term care customers, such as skilled nursing facilities, assisted living facilities, retirement centers and communities, doctors' offices, and clinics. In addition, it offers purchasing, repackaging, and dispensing of prescription and non-prescription pharmaceutical products for long term care customers. PharmCo utilizes a unit-of-dose packaging system as opposed to traditional vials used for its retail customers. Further, it provides computerized maintenance of patient prescription histories, third party billing, and consultant pharmacist services. PharmCo's consulting services primarily consist of evaluation of monthly patient drug therapy and monitoring the institution's drug distribution system. It also offers durable medical equipment in Florida. In addition, PharmCo operates as a retail pharmacy and offers traditional pharmacy services to its retail customers, as well as free home delivery twice a day. Further, it offers brand name products customary in retail drug stores, nutritional supplements, and community based products. The company was formerly known as PharmCo Corp. and changed its name in October 2010. Progressive Care, Inc. is headquartered in North Miami Beach, Florida.

On January 10, 2018, Progressive Care Inc. announced over $20 million in net revenues on approximately 225,000 prescriptions filled in 2017:
The company has been successful in breaking records in 2017.  The company announced over $20 million in net revenues, an 11% increase over 2016. The company is expecting to achieve increased growth through 2018 as well as continued reporting of strong operational and financial performance. These all-time high sales figures indicate a positive outlook for the company into the coming year. “2017 was a year of accomplishment and we are proud of all that this company has achieved,” stated S. Parikh Mars, CEO.  "Reaching $20 million in sales was a challenge this year given the ever changing climate in the healthcare industry. However, we have elevated our level of service and secured our footing for continued growth and expansion in 2018. We now embark on a new set of ambitious goals for the year. Our hard work and dedication will continue to drive us as we prepare for many possible and exciting outcomes.”

UPTICK NEWSWIRE - "Are you guys thinking about moving up to the NASDAQ?" 

CEO, Shital Mars: "Yes. So the ultimate goal has always been to become fully SEC reporting and list on NASDAQ. We think that is the right place and right path for us to go. And we think healthcare is ripe for that change and we think there’s a lot of competition and opportunity in the marketplace for a company like ours to create something special and unique and worthy of being on NASDAQ. We also know that we want to have the right vehicle for it. So it’s not something we want to do just as we are today. We want to evolve into that NASDAQ worthy company, and we are putting all the staff in place, all the factors, all the personnel and resources in place right now to get us to there as our end goal."

CEO of Progressive Care Inc., Provides 2017 Progress Report and 2018 Outlook for Investors in New Audio Interview at

Uptick Newswire “Stock Day” Interviews CEO of Progressive Care on the Completed Success in the Pharmaceutical Industry
        PharmCo is a provider of prescription pharmaceuticals, specializing in anti-retroviral patient management and durable medical equipment. The company also provides long-term care solutions
to skilled nursing facilities (SNFs), assisted living facilities (ALFs), retirement centers and communities, doctors’ offices and clinics.
Advances in HIV/AIDS treatment has greatly increased the ability of those suffering from the disease to manage their symptoms and live longer, healthier lives. Effective management of the disease begins with taking the right medications with the right dose at the right times. For those in the HIV/AIDS community, adhering to the very strict dietary and medicinal requirements can be extremely difficult. Normal activities are often interrupted and sometimes prevented by the struggle to be in compliance.
PharmCo wants to ease this burden on those impacted by this life altering disease. We aim to make compliance with prescription regiments as easy as possible. By understanding the sensitive nature of HIV/AIDS and the needs of those afflicted, PharmCo provides the following services to patients with these special needs:
1. Confidential packaging
2. Packaging tailored to suit a patient's individual life style
3. Free delivery from a variety of sources including PharmCo's proprietary delivery fleet
4. A staff that is well trained in acute illnesses, who understands the patient's needs and
5. 24 hour emergency support
6. Timely availability of specialty medications due to our extensive inventory
7. Access to newly developed medications

PharmCo is a fully accredited DME supplier. In November 2010, as part of Medicare's competitive bidding, PharmCo was awarded a three year contract to supply hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories in South Florida. PharmCo carries an extensive inventory of equipment and accessories with most special requests being honored with same day or next day delivery. The company offers both sales and rentals with size, color, style, and brand options available on the majority of products. Most importantly, the staff is knowledgeable, helpful and dedicated to providing superior customer service.
PharmCo offers home service and maintenance, defective product replacements, and free home installation and instruction.
PharmCo's institutional clients have come to depend on the company's proven accuracy, dispensing methods, and immediate response time. With PharmCo compliance and efficiency assistance, long term care institutions are able to provide the highest level of continued care to their patients. PharmCo provides purchasing, repackaging and dispensing of both prescription and non-prescription pharmaceutical products. PharmCo utilizes a unit-of-dose packaging system as opposed to traditional vials used for its retail customers. This method of distribution improves control and patient compliance with recommended drug therapy by increasing the timeliness and accuracy of medication dispensing. PharmCo also provides computerized maintenance of patient prescription histories, third party billing and consultant pharmacist services. Its consulting services consist primarily of evaluation of monthly patient drug therapy and monitoring the institution’s drug distribution system.
Long term care institutions can count on PharmCo for the following services:
     1. On time, same day deliveries available twice a day with 24 hour emergency support
     2. Language assistance in English, Spanish, French, Creole, Portuguese, Russian, and Hebrew
     3. Unit-dose packaging options tailored the facility's needs
     4. Prescription data accuracy
     5. Extensive medication and DME inventory
     6. Access to OTC medications, nutritional products and personal hygiene items
     7. Provision and review of medication carts
     8. Monthly pharmacy consultations- drug interactions, redundant therapies, side effects, etc.
     9. Compliance updates and consultations
   10. Staff Training
   11. Exceptional customer service.


901 N. Miami Beach Blvd. Suite 1, 2, North Miami Beach, FL 33162
Toll Free: 888-919-7411 Phone: 305-919-7399 Fax: 305-919-7424
Monday- Thursday          8:30 AM - 6:30 PM
Friday                              8:30 AM - 6:00 PM
Saturday                        11:00 AM - 4:00 PM

PharmCo currently services: Miami-Dade, Broward, Palm Beach, Martin, and St. Lucie Counties.
PharmCo believes its competitive advantage is to provide superior service to our customers. As a pharmacy that caters to those patients with specialty and long term health care needs, we strive to go above and beyond to give our customers the attention and care they deserve.

Our staff is specially trained in the care and management of patients with acute illnesses and HIV/AIDS. We ensure packaging that meets our customers' privacy needs and options to suit their individual life styles. We carry an extensive inventory of medications including some of the latest treatments for acute illnesses direct from manufacturers.

PharmCo takes a personal approach to customer service by providing personal attention to the doctors, clinics, LTC facilities and others who use our products and services to provide quality care for their patients. For example, on a monthly basis a PharmCo representative will consult with a facility or clinic to review drug interactions, eliminate redundancies in therapies, provide medication dispensing training, and provide updates on new regulations. PharmCo’s institutional clients have come to rely on our proven accuracy, dispensing methods and immediate response time to allow continuation of care for their patients.

For all of our customers, we facilitate a strong line of communication between their doctors, insurance providers, and care givers. Members of our diverse, multilingual staff are on hand to assist with prior authorizations and refills.Our staff often contacts insurance providers on behalf of a customer to determine coverage and help them navigate other financial assistance options. We offer free delivery to all of our customers with no minimum purchase.

Chart below courtesy of $Pistol Pete$

Posted on iHub 1/25/2016:
Post #28622 (MoneyForNuthin)

How RXMD is going to get to $1

This is a 40x improvement over today's ~$0.025 share price. Do I think it will happen this year? Though some believe it's possible, I wouldn't bet the farm on it. Do I think it's very possible within the next 3-5 years? Absolutely! Here's how and why...

First, Progressive Care, Inc. (RXMD) is clearly undervalued, but the pps is correcting and will be reaching upward for 0.10+ before you know it. Organic growth and a handful of acquisitions - simply executing the strategic plan - will do the rest. I see RXMD as a serious buyout target in 2-3 years!

Large national pharmacy companies are fending off competition from mail-order prescription discounters, online pharmacies, wholesale retailers such as Costco and health clinics, among others:

Dec 16, 2015 - CVS Health Corporation (NYSE:CVS) and Target Corporation (NYSE:TGT) announced today that CVS Health has completed the acquisition of Target's pharmacy and clinic businesses for approximately $1.9 billion.

Oct 28, 2015 - Walgreens said on Tuesday that it will buy rival Rite Aid in a $17.2 billion deal that would whittle the nation's one-time mom-and-pop drug-store industry into two massive chains. Walgreens Boots Alliance, which operates the namesake drug store chain, said it is paying $9 per share in cash in a valuation that includes the assumption of debt. That reflects a 48% premium above Rite Aid's value at the close of trading Monday.

Aug 19, 2015 - CVS Health Corp. (CVS - Analyst Report) has completed the acquisition of Ohio-based pharmacy services provider, Omnicare, for $12.7 billion, including a debt of $2.3 billion, well ahead of time. The buyout reflects the company’s foray into a new pharmacy distribution channel – the long-term specialty care market.

From a 2010 article:
Omnicare has a rich history of growth through acquisitions, which has made it a dominant player in the industry. The company boasts a reasonably sound balance sheet and is well positioned with healthy cash flow, which it can use for further acquisitions, debt repayments and share repurchases. Omnicare is pursuing an aggressive acquisition strategy in fiscal 2010. The company agreed to buy institutional pharmacy businesses in July 2010 and is also in advanced negotiations for other acquisitions.

While the goliaths have been hammering away at acquisitions and consolidation in the broader pharmacy retail sales and services markets to maximize commodity-type margins, Progressive Care, Inc. (RXMD) has been quietly whittling away at a health services business model that focuses on a small but substantial piece of the very large pie. This piece of pie, however, concentrates on high-margin revenue derived from medications and services for an underserved segment of the market. Progressive Care specializes in the care and management of patients with special needs, long-term care needs, and including medications for infectious diseases.

As stated in the Open Letter to Shareholders, Progressive Care will continue to strengthen the successful PharmCo model by "adding business elements that cater to specific under-served markets and demographics." In doing so, Progressive Care raises the bar, creating a steeper barrier to entry for regional competition in existing markets. For example, Progressive Care will add a "closed-door pharmacy facility" to the existing PharmCo operation this year. It seems likely that this will be a nearby (near the existing PharmCo site) satellite pharmacy operation embedded in a long-term care or other health services facility in one of the underserved markets/demographics of focus.

As also stated in the Open Letter to Shareholders, Progressive Care "will also look for opportunities to expand the pharmacy through establishing new locations or through mergers/acquisitions with similarly positioned independent pharmacies," and "will seek licensures in additional states in order to begin positioning PharmCo as a national brand."

Progressive Care, Inc. (RXMD) has it in the game plan to grow revenue organically and to expand into other markets nationally through acquisitions.

The goliaths have it in their game plan to continue increasing shareholder value - indefinitely. As the pending market consolidation in the major pharmacy store and services sector is nearing completion, these companies will look to the next opportunities, especially those that offer higher gross margins. They will not be able to do this organically through existing infrastructure, as the services are much more specialized than what a discount pharmacy operation can profitably support. That is, it's simply not a good product mix. The only way they will be able to continue improving shareholder value at their historic rates is through acquisitions.

If you're trading on the OTCBB and you're new to RXMD, it would be a very smart move IMO to diversify your "investments" and take 10-20% of your funds and get a starting position in this stock for the long-haul growth toward this 40-50-60x gain opportunity over 3-5-7 years. Add when you can on any dips and stay long, and use other funds for flipping other penny stocks if that's something that appeals to you. Wanna retire young? This is a road map that's easy to read

The following photo is a street view screen shot from Google on December 15, 2015
(click the image for full view)

The following images are recent photos after makeover of storefront, processing and office areas in Autumn 2015

The following pics contributed by RXMD shareholder on November 13, 2015
(click the images for complete panoramic views)

Images Of New Work Stations (Aug 2016) 

Caught some images after popping by this month of the new work stations they just installed.  Much larger work area to accomodate more people!

Developing News & Coming Events

Armen (control shareholder & company IR): "We just made this purchase, and we are excited for the added efficiencies it brings. It is not fully assembled, and will take 6-8 weeks to assemble (done by manufacturer) and it will be placed in the warehouse we are currently expanding into..connected to the pharmacy...the permits are out, and once approved we will begin the work immediately...It is $150K to purchase and assemble in total." (from INSTATRADER discussion on 1/28/16, Post #29324)

Armen (control shareholder & company IR): "This company has no conversions or debt to speak of. If we were to dilute in ANY way we would PR it first. Not only are we NOT diluting, but we expect the O/S to go DOWN when TARPON returns the 12M shares they still hold that were UNSOLD" (from INSTATRADER discussion on 1/28/16, Post #29324)

Next expected news/update... 2nd week of February: Management typically updates shareholders on monthly performance with PR disclosure to OTC Markets (and recently to iHub news)

Annual report due end of March, could post filing any time before then on OTC Markets.

Surprise news expectations... many are hoping to hear sooner than later about acquisition/merger developments for expansion of core business into new market(s) - for a surprise upward price effect beyond the current price correction in progress

Weekly Community Events (Aug 2016)

Had a chance to pop by and see the Health Fair that PharmCo was at.  Looked like several hundred people and the team was handing out A TON of PharmCo swag bags.  Spoke to the team and they say that this will be a regular thing moving forward as far as more frequent community engagement goes. I'll keep everyone posted when I can make it out to these.

Current News Summary & Status

Jan 28, 2016: "After evaluating several manufacturers of pharmacy robotic systems, PharmCo, LLC has signed an agreement to purchase ScriptPro's CRS 225 robotic prescription dispensing system, which is one of the newest additions to ScriptPro's line of compact robotic machines. The CRS 225 can hold up to 225 individual medications and fill over 1000 prescriptions per day with 99.7% counting accuracy. Under the terms of the agreement, the machine will be installed in PharmCo's facility upon completion of the site expansion build-out, which is currently in the permitting phase of completion.

"We are taking a giant leap forward in modernizing our operation by purchasing ScriptPro's robotic system. This technology will essentially eliminate human errors in the prescription filling process, and drastically increase workflow efficiency. The expansion as well as the installation of the CRS 225 will greatly increase the production capacity of the pharmacy, which will quickly produce financial benefits for the Company," stated S. Parikh Mars, CEO."

Jan 14, 2016: "The pharmacy filled nearly 180,000 prescriptions in 2015, which is a 28% increase over last year. During the fourth quarter, PharmCo filled over 48,000 prescriptions resulting in record revenues for the quarter at $3.9 million. December marked the strongest month for the company since inception with over $1.4 million in net pharmacy revenues.

In 2015, PharmCo brought in over $13.5 million in net pharmacy revenues. This is almost a 24% increase over 2014. Revenue growth accelerated during the final month and quarter with over 61% and 35% increases in revenues, respectively, when compared to the same time periods last year. The compounded medication division is the primary driver of revenue growth in addition to major additions to company's marketing team and expanded marketing campaigns with large clinics and physicians networks.

"While I am supremely happy with the progress we have made over the past year, I know that this is merely a fraction of what the company is capable of in the future. I am excited about bringing the company into 2016 with an ambitious resolve to accomplish major goals and realize our utmost potential. Our shareholders should take this time to share in the company's joy, but ready themselves for major growth and expansion in the coming year," stated Shital Parikh Mars, CEO."

Jan 8, 2016: "Upon review of the filings and approval from OTC Markets, Progressive Care has moved to the OTC Pink Current Information tier of listed companies which is the highest trading tier on the OTC Pink marketplace. Over the past year, the Company has been diligent with filing all disclosure documents and financial statements with OTC Markets in a timely manner. As a result the company will now trade without a yield sign for the first time since 2013. Achieving the highest tier in the OTC Pink marketplace will bring significant benefits to the Company and its shareholders by assuring the public that comprehensive information on the Company's operations and financials is readily available.

"Over the past month, our management team has worked steadily to ensure that all disclosure and document requirements of OTC Markets have been met. Becoming an OTC Pink Current company is a positive step forward for Progressive Care. By providing greater transparency and public confidence in the timeliness and accuracy of press releases, financial statements and disclosures, we believe that we will strengthen our shareholder base and build shareholder value," stated Shital Parikh Mars, CEO."

Jan 7, 2016: Open Letter to Shareholders... "The New Year is often a time of earnest reflection on the developments of last year and ambitious goal-setting for the year ahead. I am pleased to say that 2015 was a year of transformation and tremendous progress for the Company. In the past year, we have cemented ourselves as a health services organization that goes beyond being a provider of prescription pharmaceuticals and our numerous achievements have positioned us for further growth and success in 2016." (Read More)

$RXMD recent news/filings

April 2, 2018 Progressive Care Enters Into Definitive Agreements to Purchase the Pharmacy in Palm Beach County

March 23, 2018 Progressive Care  Releases Audited 2017 Annual Report 

March 16, 2018 Progressive Care Reports 18% Increase in Year over Year Prescriptions Filled During February 2018

March 2, 2018 Progressive Care Executes Letter of Intent to Purchase a Pharmacy in Palm Beach County

Feb. 13, 2018 Progressive Care Breaks Record with Over 23,000 Prescriptions Filled in January 2018

Jan. 10, 2018 Progressive Care Continues to Break Records with Over $20 Million in Sales

Dec. 5, 2017 OTC Markets Group Welcomes New OTCQB Companies

Dec. 4, 2017  Uptick Newswire “Stock Day” Interviews CEO of Progressive Care on the Completed Success in the Pharmaceutical Industry

Nov. 15, 2017  Progressive Care Reports Stellar Third Quarter Results

Sept. 25, 2017 Progressive Care Appoints Oleg Firer as an Independent Board Member

Sept. 19, 2017 Progressive Care Reports $1.8 Million Revenues on 20,000 Prescriptions in August

Aug. 23, 2017  Progressive Care Reports $1.7 Million in Revenues in July

Aug. 7, 2017 Progressive Care Announces New Independent Board Member: Jervis Hough, MS, CSCP

Jul 14, 2017 Progressive Care Reports Second Quarter Status Update

Jun 8, 2017 Progressive Care Reports 18% Increase in Revenue for April and May 2017

May 17, 2017 Progressive Care Reports First Quarter 2017 Results

May 12, 2017 Progressive Care Announces First Quarter Conference Call and Webcast with Investors on May 15, 2017

May 12, 2017 Progressive Care Initiates Process to Upgrade to OTCQB

Apr 21, 2017 Progressive Care Increases Revenue by 10% for March 2017

Apr 13, 2017 Progressive Care Partners with Healthcare IT Company MDFlow Systems

Apr 4, 2017 Progressive Care Releases Audited 2016 Annual Report

Mar 31, 2017 Progressive Care Announces Fourth Quarter Conference Call and Webcast with Investors on April 3, 2017

Mar 16, 2017 Progressive Care Increases Revenue by 36% for February 2017

Mar 3, 2017 Progressive Care Issues Update on Recent Legal Proceedings

Feb 28, 2017 Progressive Care Increases Revenue by 22% for January 2017

Feb 21, 2017 Progressive Care Issues Update on Recent Trading Volume

Feb 16, 2017 Progressive Care Slated to Present at SeeThru Equity Conference in Miami

Feb 15, 2017 Progressive Care Releases Open Letter to Shareholders

Jan 25, 2017 Progressive Care Engages PCAOB Auditing Firm to Begin Audit of 2016 Financial Statements

Jan 23, 2017 Progressive Care: PharmCo Signs 340B Agreement with Community AIDS Network

Jan 20, 2017 Progressive Care Beats Expectations with over $18 Million in 2016 Revenues

Jan 17, 2017 Progressive Care: PharmCo Opens Resource Center in Century Village

read full:
## source:

Thu, 28 Jan 2016 13:00:00 GMT ~ Progressive Care: PharmCo Purchases ScriptPro Robotic Dispensing System

[Marketwired] - Progressive Care Inc. , through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded ...

read full:

Fri, 15 Jan 2016 15:03:00 GMT ~ e Research on Progressive Care, Stevia Corp, Titan Medical, and Usinas Siderurgicas de Minas Gerais

[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 15, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Progressive ...

read full:

Thu, 14 Jan 2016 13:00:00 GMT ~ Progressive Care Revenue Soars to Over $13 Million on 180,000 Filled Prescriptions

[Marketwired] - Progressive Care Inc. , through its subsidiary PharmCo, LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded ...

read full:

Mon, 11 Jan 2016 14:12:00 GMT ~ Markets Are Red Again But Some Safe Haven Stocks Continue To Weather the Storm

[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 11, 2016 / About 5 months ago I wrote a piece on safe haven stocks to pay attention to especially after a particularly bloody week in the market. Well here we are again, ...

read full:

Fri, 08 Jan 2016 14:24:53 GMT ~ Progressive Care Inc. Upgrades to OTC Pink Current Information Tier

[Marketwired] - Progressive Care Inc. , through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, the ...

read full: 

Ticker: $RXMD
OTC Market Place: OTCQB
CIK code: 0001402945
Company name: Progressive Care, Inc.
Company website:
Incorporated In: DE, USA

$RXMD extra dd links

After Hours Quote (
Option Chain (
Historical Prices (
Company Profile (
Industry (

Market Stream (
Latest news ( -

Analyst Research (
Guru Analysis (
Stock Report (
Competitors (
Stock Consultant (
Stock Comparison (
Investopedia (
Research Reports (
Basic Tech. Analysis (
Barchart (
Spoke company information (
Corporation WIKI (
WHOIS ( "" rel="nofollow" target="_blank">; rel="nofollow" target="_blank">
Alexa ( "" rel="nofollow" target="_blank">; rel="nofollow" target="_blank">
Corporate website internet archive ( "" rel="nofollow" target="_blank">; rel="nofollow" target="_blank">*/

Call Transcripts (
Annual Report (
Income Statement (
Revenue/EPS (
SEC Filings (
Edgar filings (
Latest filings (
Latest financials (
Short Interest (
Dividend History (
RegSho (
OTC Short Report (
Short Sales (
Key Statistics (
Insider Roster (
Income Statement (
Balance Sheet (
Cash Flow (

Major holdings (
Insider transactions (
Insider transactions (
Insider transactions (
Ownership Summary (
Institutional Holdings (
Insiders (SEC Form 4) (
Insider Disclosure (

Market Watch (
Bloomberg (
Morningstar (
Bussinessweek (
Cannabis Report
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
RXMD News: Progressive Care Signs Two New 340B Contracts to Bring Discounted Prescription Programs to Non-Profit Healthcare Institutions 07/19/2018 08:00:00 AM
RXMD News: Progressive Care Inc. Announces Month-End Sales Figures Showing Increase in Year-Over-Year Prescriptions Filled in June 2018 07/17/2018 03:02:16 PM
RXMD News: Progressive Care Launches New DischargeRX Program to Improve Engagement Between Patients and Hospitals 07/13/2018 06:20:29 PM
RXMD News: S. Parikh Mars, CEO of Progressive Care, Discusses Recent Company and Industry News in New Audio Interview with SmallCapVoice 07/03/2018 04:27:48 PM
RXMD News: Progressive Care Completes Acquisition of Touchpoint Pharmacy Expanding Company Footprint and Market Oppotunity MIAMI July X, 07/02/2018 12:45:32 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#95770  Sticky Note RXMD OTCQB: Record Sales! Expansion! 14 State Licences! times2times2 07/02/18 12:52:57 PM
#92121  Sticky Note RXMD IS ON A COURSE FOR SUCCESS, ON Jimmy Quick 05/24/18 03:22:03 PM
#86158  Sticky Note Rumored Walmart Deal Adds Value and More to stockforce 04/18/18 05:15:24 PM
#76605  Sticky Note UPDATED: RXMD The Best Stock Investment For 2018 don't know 03/14/18 07:32:20 PM
#67912  Sticky Note RXMD NEWS Record 20 Million Sales in 2017 Davis_Elite 02/01/18 08:41:06 AM
#97315   To think that anyone cares or listens to Wildcats2 07/23/18 09:42:11 AM
#97314   LOL, But I think he is too busy minkman63 07/23/18 09:34:56 AM
#97313   MaarshallDave I strongly suggest you go to Progressive and mickeybritt 07/23/18 09:32:13 AM
#97312   To think that a 1 Million a year MarshallDave 07/23/18 09:21:35 AM
#97311   That is actually very helpful. Sheds a Jimmy Quick 07/23/18 09:04:32 AM
#97310   There are so many great reasons I'm invested TheSerb 07/23/18 08:33:43 AM
#97309   I glanced over this, what stuck out to Pirdboop 07/23/18 08:31:54 AM
#97308 I alway Stocked55 07/22/18 11:47:41 PM
#97307   First off when they signed CV agreement they Jimmy Quick 07/22/18 10:22:58 PM
#97306   So how do you Explain , RXMD...a FIFTY MarshallDave 07/22/18 07:39:29 PM
#97303   Nice Summary gedi8 07/22/18 05:05:37 PM
#97301   Everything has changed in 2018, but some want Jimmy Quick 07/22/18 03:01:54 PM
#97300   As long as the company continues to get Sunblazers 07/22/18 02:32:51 PM
#97299   RXMD: should cough up Friday's pump fake gains straighttalk2004 07/22/18 01:28:26 PM
#97298   but with " significantly reduced prices " how colorfullife88200 07/22/18 12:46:43 PM
#97297   Well laid out ... JohnCM 07/21/18 11:00:03 PM
#97296   Kids not getting a good smack on the Turbomunkey 07/21/18 10:14:20 PM
#97295   Why the argument about gross margins is meaningless, ArmoredDragon 07/21/18 09:42:39 PM
#97293   Hey Mick, but what about all those football TrackDude 07/21/18 03:39:24 PM
#97292   Crumbster I tried to explain the proper terminology. You mickeybritt 07/21/18 02:39:05 PM
#97291 JohnCM 07/21/18 11:59:22 AM
#97290   you deserve a good slap on the back Crumbster 07/21/18 11:42:21 AM
#97289   This forum is very quite Fat-man 07/21/18 10:52:23 AM
#97286   I think the 340B contracts are a pretty ArmoredDragon 07/20/18 11:26:37 PM
#97285   Agree 100% correct hold and get rewarded Fat-man 07/20/18 10:24:41 PM
#97283   Even if RXMD margins are low (they're not) ArmoredDragon 07/20/18 08:30:52 PM
#97282   Crumbster I guess when your friends like you the mickeybritt 07/20/18 06:36:01 PM
#97281   i don't have any doubt there..just look at Grizzerbear 07/20/18 05:41:26 PM
#97276   Lamenting on 1 quarter is not good business Jimmy Quick 07/20/18 05:17:49 PM
#97273   Friendly Reminder to All Jimmy Quick 07/20/18 04:57:11 PM
#97272   Disregarding the Trend of Reimbursements Contracting ... will MarshallDave 07/20/18 04:56:53 PM
#97271   Thanks and very welcome. Good Luck to you! Jimmy Quick 07/20/18 04:51:42 PM
#97270   Do you know what the increase was from Jimmy Quick 07/20/18 04:50:33 PM
#97269   Thanks for your work on this Jimmy, great Krig 07/20/18 04:45:54 PM
#97268   RXMD FILINGS Gross Margin DECLINES 8%>>>>>>>>>>>> MarshallDave 07/20/18 04:44:46 PM
#97267   Gross Profit Margin average for 2017 was 27.2%. Jimmy Quick 07/20/18 04:28:38 PM
#97266   So RXMD Gross Margin and Profit Dropping 8% MarshallDave 07/20/18 04:19:43 PM
#97265   LOL, oh just RXMD's. Oh so they Jimmy Quick 07/20/18 04:16:51 PM
#97264   Not if you understand how RXMD Payroll and MarshallDave 07/20/18 04:12:58 PM
#97263   It's all going to add up. Estimate Jimmy Quick 07/20/18 04:09:46 PM
#97262   Yup, Also ha shiatory of shareholders selling way myantis 07/20/18 04:07:07 PM
#97261   "LUCRATIVE"... Seriously with only 5% Margin. Won't even MarshallDave 07/20/18 03:48:21 PM
#97260   .12 next week? Seems like bottom in and Richard333 07/20/18 03:48:13 PM
#97259   Rep. Tim Ryan: Marijuana should be legal in DGStocks 07/20/18 03:09:44 PM
#97258   Thanks JQ. gedi8 07/20/18 03:03:37 PM
#97257   @PharmCoRX Twitter post: Interacting with the community makes a Jimmy Quick 07/20/18 03:02:31 PM
#97256   ProgressiveCare Inc twitter posts We believe that the success Jimmy Quick 07/20/18 03:00:07 PM
#97255   The Two New Lucrative 340B Contracts Signed Jimmy Quick 07/20/18 02:59:20 PM
#97254   slap the ask, whack the bid, works for me Crumbster 07/20/18 02:49:55 PM
#97253   The Serb mickeybritt 07/20/18 02:14:58 PM